Company research
Fetched today
Sharp Biomedical builds minimally invasive spinal devices and safe, manual procedures for interventional pain physicians and outpatient pain clinics, aiming to move procedures out of hospitals and into surgery centers.
- Founders
- Dan Newman · Founder and CEOHe was a doctoral student in the University of North Dakota's Biomedical Engineering Department.
- Dan Newman · Founder and CEO
WHY IT MATTERS
Sharp Biomedical is targeting an unmet need earlier in the chronic-pain care continuum with a small implant and manual procedures that can be performed in outpatient settings, reducing reliance on hospital infrastructure, robotics, and prolonged operating times. Its October 2026 pre-seed round, led by gener8tor 1889, is intended to fund development and testing of the first toolset and implant system ahead of a planned Q4 2027 launch.
Sources
Pre-seed2026-10-125 sources
- https://de.advfn.com/borse/nachrichten/99476674/sharp-biomedical-closes-pre-seed-funding-led-by-gede.advfn.com · today
- Sharp Biomedical Closes Pre-Seed Funding Led by Gener8tor to Advance Outpatient Spine Procedures for Early-to-Mid-Stage Chronic Painalso on finance.yahoo.com, pr.capitalpress.com, morningstar.comprnewswire.com · today
Investors
Pre-seed2026-10-121 investor
gener8tor 1889[ LEAD ]
Also named as backers in company research: UND Center for Innovation, gBETA, Runway Accelerator